Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind Tolerability Trial of Cannabinoids for Symptom Management in Children With Cancer: the CAN-PONC Trial
Conditions
Interventions
MPL-001
MPL-005
+1 more
Start Date
June 1, 2025
Primary Completion Date
March 31, 2027
Completion Date
March 31, 2027
Last Updated
May 29, 2025
NCT04541381
NCT05468034
NCT07549477
NCT06594926
NCT06844383
NCT05398783
Lead Sponsor
University of Manitoba
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions